Cutting-edge test detects early tumor recurrence in some cancers
(NEW YORK) -- A new blood test seeks to change the game in cancer management.Signatera, a "tumor-informed" blood test developed by Natera, can detect circulating tumor DNA in the bloodstream for certain types of cancers."What makes the tumor DNA different is that it has...